Cutaneous follicle center lymphoma, lymph nodes of inguinal region and lower limb
ICD-10 C82.65 is a billable code used to indicate a diagnosis of cutaneous follicle center lymphoma, lymph nodes of inguinal region and lower limb.
Cutaneous follicle center lymphoma (CFCL) is a type of non-Hodgkin lymphoma that primarily affects the skin and can involve lymph nodes. It is characterized by the proliferation of follicle center (germinal center) B-cells. When CFCL involves the lymph nodes of the inguinal region and lower limb, it indicates a more advanced stage of the disease, often associated with systemic symptoms. Patients may present with localized skin lesions, which can be mistaken for other dermatological conditions. The disease can manifest with B-symptoms such as fever, night sweats, and weight loss, indicating a more aggressive form of lymphoma. Diagnosis typically involves a combination of clinical evaluation, imaging studies, and biopsy of affected lymph nodes or skin lesions. Treatment options may include localized radiation therapy, chemotherapy, or immunotherapy, depending on the stage and severity of the disease. Regular follow-up is essential to monitor for disease progression or recurrence.
Detailed clinical notes on patient history, physical examination findings, and treatment plans.
Diagnosis and management of cutaneous lymphomas, staging evaluations, and treatment response assessments.
Ensure comprehensive documentation of all symptoms and treatment responses to support coding.
Thorough descriptions of skin lesions, biopsy results, and any associated symptoms.
Evaluation of skin lesions suspected to be lymphoma and coordination with oncology for treatment.
Document the appearance and location of lesions clearly to avoid misclassification.
Used when a biopsy of skin lesions is performed to confirm CFCL.
Pathology report must be included in the patient's medical record.
Ensure that the pathology report clearly indicates the diagnosis of CFCL.
Common symptoms include skin lesions, swollen lymph nodes, and systemic symptoms such as fever, night sweats, and weight loss.
Treatment may include localized radiation therapy, chemotherapy, or immunotherapy, depending on the stage and severity of the disease.
